N-(1-(2-((3-Cyanophenyl)amino)-2-oxoethyl)-2,3-dioxoindolin-5-yl)butyramide

ID: ALA4514521

PubChem CID: 155539382

Max Phase: Preclinical

Molecular Formula: C21H18N4O4

Molecular Weight: 390.40

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCC(=O)Nc1ccc2c(c1)C(=O)C(=O)N2CC(=O)Nc1cccc(C#N)c1

Standard InChI:  InChI=1S/C21H18N4O4/c1-2-4-18(26)23-15-7-8-17-16(10-15)20(28)21(29)25(17)12-19(27)24-14-6-3-5-13(9-14)11-22/h3,5-10H,2,4,12H2,1H3,(H,23,26)(H,24,27)

Standard InChI Key:  HIRFQDUHVIUBDA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
    8.0756  -17.6067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0744  -18.4263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7825  -18.8352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7807  -17.1979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4893  -17.6031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4941  -18.4217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2741  -18.6702    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7515  -18.0051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2664  -17.3457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5687  -18.0002    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5143  -16.5670    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.2685  -19.4846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9734  -19.8981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3678  -17.1983    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6601  -17.6071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9523  -17.1986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6603  -18.4242    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2447  -17.6074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9678  -20.7153    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.6839  -19.4943    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3888  -19.9078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3816  -20.7239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0857  -21.1372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7971  -20.7334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8001  -19.9120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0955  -19.5023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5070  -19.5064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2161  -19.1001    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5369  -17.1990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  8 10  2  0
  9 11  2  0
  7 12  1  0
 12 13  1  0
  1 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 13 19  2  0
 13 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 27 28  3  0
 25 27  1  0
 18 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4514521

    ---

Associated Targets(Human)

Z-138 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JeKo-1 (376 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Maver1 (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 390.40Molecular Weight (Monoisotopic): 390.1328AlogP: 2.46#Rotatable Bonds: 6
Polar Surface Area: 119.37Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.26CX Basic pKa: CX LogP: 1.97CX LogD: 1.97
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.73Np Likeness Score: -1.69

References

1. Yu S, Liu Y, Zhang Z, Zhang J, Zhao G..  (2019)  Design, synthesis and biological evaluation of novel 2,3-indolinedione derivatives against mantle cell lymphoma.,  27  (15): [PMID:31229421] [10.1016/j.bmc.2019.06.009]

Source